The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Astonin     (8S,9S,10S,11S,13S,14S,17R)- 9-fluoro-11,17...

Synonyms: FCOL, Astonin-H, Astonin H, Astonin Merck, Merck, Astonin, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of fludrocortisone


Psychiatry related information on fludrocortisone


High impact information on fludrocortisone


Chemical compound and disease context of fludrocortisone


Biological context of fludrocortisone


Anatomical context of fludrocortisone


Associations of fludrocortisone with other chemical compounds


Gene context of fludrocortisone


Analytical, diagnostic and therapeutic context of fludrocortisone


  1. Fludrocortisone in orthostatic hypotension. Walter, R. N. Engl. J. Med. (1979) [Pubmed]
  2. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. Chobanian, A.V., Volicer, L., Tifft, C.P., Gavras, H., Liang, C.S., Faxon, D. N. Engl. J. Med. (1979) [Pubmed]
  3. Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism. Sebastian, A., Schambelan, M., Lindenfeld, S., Morris, R.C. N. Engl. J. Med. (1977) [Pubmed]
  4. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. Rowe, P.C., Calkins, H., DeBusk, K., McKenzie, R., Anand, R., Sharma, G., Cuccherini, B.A., Soto, N., Hohman, P., Snader, S., Lucas, K.E., Wolff, M., Straus, S.E. JAMA (2001) [Pubmed]
  5. Evidence that patients with Addison's disease are undertreated with fludrocortisone. Smith, S.J., MacGregor, G.A., Markandu, N.D., Bayliss, J., Banks, R.A., Prentice, M.G., Dorrington-Ward, P., Wise, P. Lancet (1984) [Pubmed]
  6. Mineralocorticoid receptor function in posttraumatic stress disorder after pretreatment with metyrapone. Otte, C., Muhtz, C., Daneshkhah, S., Yassouridis, A., Kiefer, F., Wiedemann, K., Kellner, M. Biol. Psychiatry (2006) [Pubmed]
  7. Differential mood response to natural and synthetic corticosteroids after bilateral adrenalectomy: a case report. Seifritz, E., Hemmeter, U., Pöldinger, W., Froesch, E.R., Reul, J.M., Holsboer-Trachsler, E. Journal of psychiatric research. (1994) [Pubmed]
  8. Treatment of orthostatic hypotension with erythropoietin. Hoeldtke, R.D., Streeten, D.H. N. Engl. J. Med. (1993) [Pubmed]
  9. An inhibitor of sodium transport in the urine of dogs with normal renal function. Favre, H., Hwang, K.H., Schmidt, R.W., Bricker, N.S., Bourgoignie, J.J. J. Clin. Invest. (1975) [Pubmed]
  10. Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension. La Villa, G., Salmerón, J.M., Arroyo, V., Bosch, J., Ginés, P., García-Pagán, J.C., Ginés, A., Asbert, M., Jiménez, W., Rivera, F. Gastroenterology (1992) [Pubmed]
  11. Hyponatremia responsive to fludrocortisone acetate in elderly patients after head injury. Ishikawa, S.E., Saito, T., Kaneko, K., Okada, K., Kuzuya, T. Ann. Intern. Med. (1987) [Pubmed]
  12. Idiopathic hypovolemia. Fouad, F.M., Tadena-Thome, L., Bravo, E.L., Tarazi, R.C. Ann. Intern. Med. (1986) [Pubmed]
  13. Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study. Blockmans, D., Persoons, P., Van Houdenhove, B., Lejeune, M., Bobbaers, H. Am. J. Med. (2003) [Pubmed]
  14. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia. Merke, D.P., Keil, M.F., Jones, J.V., Fields, J., Hill, S., Cutler, G.B. J. Clin. Endocrinol. Metab. (2000) [Pubmed]
  15. Fludrocortisone suppression of sympathetic nervous activity. Izzo, J.L., Horwitz, D., Lawton, W.J., Keiser, H.R. Clin. Pharmacol. Ther. (1983) [Pubmed]
  16. Hyperkalemia in acute glomerulonephritis due to transient hyporeninemic hypoaldosteronism. Don, B.R., Schambelan, M. Kidney Int. (1990) [Pubmed]
  17. Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Jacob, G., Shannon, J.R., Black, B., Biaggioni, I., Mosqueda-Garcia, R., Robertson, R.M., Robertson, D. Circulation (1997) [Pubmed]
  18. Volume-pressure relationships during development of mineralocorticoid hypertension in man. Wenting, G.H., Man in 't Veld, A.J., Verhoeven, R.P., Derkx, F.H., Schalekamp, D.H. Circ. Res. (1977) [Pubmed]
  19. Hyponatremia due to cerebral salt-wasting syndrome. Combined cerebral and distal tubular lesion. Al-Mufti, H., Arieff, A.I. Am. J. Med. (1984) [Pubmed]
  20. The mineralocorticoid receptor may compensate for the loss of the glucocorticoid receptor at specific stages of mammary gland development. Kingsley-Kallesen, M., Mukhopadhyay, S.S., Wyszomierski, S.L., Schanler, S., Schütz, G., Rosen, J.M. Mol. Endocrinol. (2002) [Pubmed]
  21. Defective aldosterone synthesis associated with hyperkalemic periodic paralysis. Allen, D.B. Arch. Neurol. (1993) [Pubmed]
  22. Adrenocortical steroids increase renal thiazide diuretic receptor density and response. Chen, Z., Vaughn, D.A., Blakely, P., Fanestil, D.D. J. Am. Soc. Nephrol. (1994) [Pubmed]
  23. Close association of urinary excretion of aquaporin-2 with appropriate and inappropriate arginine vasopressin-dependent antidiuresis in hyponatremia in elderly subjects. Ishikawa Se, n.u.l.l., Saito, T., Fukagawa, A., Higashiyama, M., Nakamura, T., Kusaka, I., Nagasaka, S., Honda, K., Saito, T. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  24. Cortisol metabolism by human liver in vitro--IV. Metabolism of 9 alpha-fluorocortisol by human liver microsomes and cytosol. Abel, S.M., Back, D.J., Maggs, J.L., Park, B.K. J. Steroid Biochem. Mol. Biol. (1993) [Pubmed]
  25. Recovery of adrenal function after treatment of adrenocortical carcinoma with o,p'-DDD. Greig, F., Oberfield, S.E., Levine, L.S., Ghavimi, F., Pang, S., New, M.I. Clin. Endocrinol. (Oxf) (1984) [Pubmed]
  26. Esmolol tilt testing with esmolol withdrawal for the evaluation of syncope in the young. Ovadia, M., Thoele, D. Circulation (1994) [Pubmed]
  27. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog. Pescovitz, O.H., Comite, F., Cassorla, F., Dwyer, A.J., Poth, M.A., Sperling, M.A., Hench, K., McNemar, A., Skerda, M., Loriaux, D.L. J. Clin. Endocrinol. Metab. (1984) [Pubmed]
  28. Bioassay of a new aldosterone antagonist and evaluation of a simple method of quantitative comparison. McInnes, G.T., Shelton, J.R., Asbury, M.J., Harrison, I.R., Clarke, J.M., Ramsay, L.E., Venning, G.R. Clin. Pharmacol. Ther. (1981) [Pubmed]
  29. Dose-response relationships for spironolactone in combination with a potassium-wasting diuretic. McInnes, G.T., Clarke, J.M., Shelton, J.R. Clin. Pharmacol. Ther. (1983) [Pubmed]
  30. Inappropriate adrenal androgen secretion with once-a-day corticosteroid therapy for congenital adrenal hyperplasia. Keenan, B.S., Eberle, A.E., Lin, T.H., Clayton, G.W. J. Pediatr. (1990) [Pubmed]
  31. Mineralocorticoid and glucocorticoid receptors and their differential effects on memory performance in people with Addison's disease. Tytherleigh, M.Y., Vedhara, K., Lightman, S.L. Psychoneuroendocrinology (2004) [Pubmed]
  32. Angiotensin II feedback is a regulator of renocortical renin, COX-2, and nNOS expression. Kammerl, M.C., Richthammer, W., Kurtz, A., Krämer, B.K. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2002) [Pubmed]
  33. Structural basis for the glucocorticoid response in a mutant human androgen receptor (AR(ccr)) derived from an androgen-independent prostate cancer. Matias, P.M., Carrondo, M.A., Coelho, R., Thomaz, M., Zhao, X.Y., Wegg, A., Crusius, K., Egner, U., Donner, P. J. Med. Chem. (2002) [Pubmed]
  34. Effects of fludrocortisone withdrawal on plasma angiotensin II, ACTH, vasopressin, and potassium in patients with Addison's disease. Oelkers, W., Bähr, V. Acta Endocrinol. (1987) [Pubmed]
  35. The diurnal rhythm of adrenocorticotropic hormone secretion in the assessment of the adequacy of replacement therapy in primary chronic adrenal failure. Fadeev, V.V., Gitel, E.P., Mel'nichenko, G.A. Neurosci. Behav. Physiol. (2001) [Pubmed]
  36. 9-Alpha-fluorohydrocortisone in the treatment of postural hypotension in diabetic autonomic neuropathy. Campbell, I.W., Ewing, D.J., Clarke, B.F. Diabetes (1975) [Pubmed]
  37. Full recovery from severe orthostatic hypotension after vacor rodenticide ingestion. Osterman, J., Zmyslinski, R.W., Hopkins, C.B., Cartee, W., Lin, T., Nankin, H.R. Arch. Intern. Med. (1981) [Pubmed]
  38. Molecular and functional studies of electrogenic Na(+) transport in the distal colon and rectum of young and elderly subjects. Greig, E.R., Mathialahan, T., Boot-Handford, R.P., Sandle, G.I. Gut (2003) [Pubmed]
  39. Orthostatic hypotension. II. Clinical diagnosis, testing, and treatment. Schatz, I.J. Arch. Intern. Med. (1984) [Pubmed]
  40. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome. Peterson, P.K., Pheley, A., Schroeppel, J., Schenck, C., Marshall, P., Kind, A., Haugland, J.M., Lambrecht, L.J., Swan, S., Goldsmith, S. Arch. Intern. Med. (1998) [Pubmed]
WikiGenes - Universities